Menu
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Its Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.
135 Duryea Rd
Melville, New York 11747-3834
Phone: 16318435500
www.henryschein.com
Henry Schein, Inc. (Nasdaq: HSIC), the National Dental Association (NDA), and the Schattner Foundation just completed the second year of an innovative program designed to inspire students from historically underrepresented backgrounds to enter the dental profession. The S.M.I.L.E. (Student Mentoring with Immersive Learning and Enrichment) Healthcare Pathway Program aims to advance oral health Jetzt den vollständigen Artikel lesen
Mark E Mlotek , EVP at Henry Schein (NASDAQ: HSIC ), reported an insider sell on August 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Mlotek sold 3,000 shares of Henry Schein . The total transaction amounted to $207,360. The latest update on Friday morning shows Henry Schein shares down by 0.0%, trading at $69.78. Unveiling the Story Behind Henry Schein Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Morgan Stanley 22nd Annual Global Healthcare Conference in New York on September 5, 2024, at 11:30 a.m. Eastern time. Baird 2024 Global Healthcare Conference Jetzt den vollständigen Artikel lesen
For the 27th consecutive year, Henry Schein, Inc. (Nasdaq: HSIC) is helping students worldwide start the academic year off right through its “Back to School” program, a flagship initiative of Henry Schein Cares, the Company’s global corporate citizenship program. Team Schein Members (TSMs) at 40 locations in the U.S., Canada, U.K., and Ireland are helping 5,300 students gain confidence and Jetzt den vollständigen Artikel lesen
Henry Schein, Inc. (NASDAQ:NASDAQ:HSIC) Q2 2024 Earnings Conference Call August 6, 2024 10:00 AM ETCompany ParticipantsGraham Stanley - VP, IR &…
Henry Schein (NASDAQ: HSIC ) just reported results for the second quarter of 2024. Henry Schein reported earnings per share of $1.23. This met the analyst estimate for EPS of $1.23. The company reported revenue of $3.14 billion. This was 4.10% worse than the analyst estimate for revenue of $3.27 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post HSIC Stock Earnings: Henry Schein Meets EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace .
Henry Schein (HSIC) stock falls as the company cuts full-year outlook with Q2 results, citing an impact from a cyber incident and economic headwinds. Read more here.
On Tuesday, Henry Schein Inc (NASDAQ: HSIC ) reported a second-quarter adjusted EPS of $1.23, down 6.1% year-over-year, beating the consensus of $1.22 . Sales were $3.10 billion, an increase of 1%, missing the consensus of $3.27 billion . Sales growth reflects 4.0% growth from acquisitions, a 0.5% decrease resulting from foreign exchange rates, a 0.5% sales decrease from lower sales of personal protective equipment (PPE), primarily the result of lower glove pricing, and the pace of recovery from the cyber incident late last year. Internal sales decreased by 2.4%, including a 0.5% decrease from lower PPE sales. Global dental segment sales were $1.9 billion, down 1.7%, and medical segment sales increased by 5% to $1 billion. Technology … Full story available on Benzinga.com
MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) revealed a profit for second quarter that decreased from last year but beat the Street estimates.The company''s earnings came in at $104 million, or $0…
